A Century After Its Discovery, VWD Remains Dramatically Underdiagnosed Worldwide – RPTH Journal
RPTH Journal shared on LinkedIn about a recent article by Omid Seidizadeh et al, adding:
”A century after its discovery, von Willebrand disease (VWD) remains dramatically underdiagnosed worldwide.
A new RPTH review highlights one of the most striking paradoxes in hematology.
Although VWD is the most common inherited bleeding disorder, the vast majority of affected individuals remain undiagnosed or misdiagnosed.
The numbers are staggering:
- Population studies estimate VWD prevalence at 0.8%–1.6%
- At least 1 in 1000 individuals likely has a clinically significant disease
- Yet global registry prevalence averages only 25.6 per million
Many patients experience:
- recurrent mucosal bleeding
- iron deficiency anemia
- chronic fatigue
- impaired quality of life
- missed school/work
- delayed surgical or obstetric recognition
Why does underdiagnosis persist after 100 years?
The review outlines several key barriers:
- Limited awareness among clinicians and the public
- Poor access to specialized VWF testing
- Biological variability of VWF levels
- Complex and heterogeneous phenotypes
- Assay variability and diagnostic inconsistency
- Misclassification as platelet disorders or hemophilia A
Meaning patients may intermittently appear ‘normal’ in routine testing.
The paper also highlights major global inequities. In low- and middle-income countries, only the most severe VWD phenotypes are typically diagnosed due to limited access to specialized laboratory infrastructure.
The message of this review is powerful:
The next century of VWD should not focus only on discovering new biology, but on ensuring patients are actually diagnosed.
A thoughtful and important review bridging bleeding disorders, women’s health, global health equity, diagnostic medicine, and laboratory hematology.”
Title: Beyond a century of discovery: the global and persistent burden of underdiagnosis in von Willebrand disease
Authors: Omid Seidizadeh, Rezan Abdul-Kadir, Pier Mannuccio Mannucci, Flora Peyvandi

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation
-
Jul 13, 2026, 22:33ESOC 2026 recordings are now available on eSTEP – European Stroke Organisation
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026